Akero Therapeutics (AKRO) saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 79 to 82. Looking For The Best Stocks To Buy And Watch? Start Here This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The grade shows how a stock's price movement over…